DPIIT recognised startup Government of India
Startup India
Casid Pharmaceuticals Private Limited
Casid Pharmaceuticals Private Limited - pharma in Manachanalloor, Tamil Nadu, India. Directors, charges & compliance details.
Revenue · FY 2025
₹74.41 Cr
▲ 28% YoY
Net profit · FY 2025
₹15.08 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹50.27 Lakh
EBITDA margin 0.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
7
Provident fund records
Directors on board
2
As per MCA filings
About Casid Pharmaceuticals Private Limited
Data last updated:
Casid Pharmaceuticals Private Limited is a private limited company based in Manachanalloor, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2019PTC130614. Its GSTIN is 33AAICC2892D1ZT (Tamil Nadu).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹10 Lakh. It is led by directors Nirmal Kathiravan and Shivakumar Nagulan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Manachanalloor, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹74.41 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹15.08 Lakh (net margin 0.2%) and EBITDA of ₹50.27 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 258% over three years and 234% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
Casid Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-22-0022808). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TN2019PTC130614
Registration Number 130614
Incorporation Date 19 July 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-TN-22-0022808
Recognitions & Rankings of Casid Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-22-0022808
Contact details
Casid Pharmaceuticals Private Limited's registered office is in Manachanalloor, Tamil Nadu.
- Registered AddressS.F. No. 115/15 Trichy To Chennai Trunk Road, Samayyapuram Village And Panchayat Manachanalur Taluk, Manachanalloor, Tamil Nadu, India – 621112
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Casid Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Casid Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Casid Pharmaceuticals Private Limited, buy the company report.
Financials of Casid Pharmaceuticals Private Limited
FY 2025 filings availableCasid Pharmaceuticals Private Limited reported revenue of ₹74.41 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹74.41 Cr ▲ 28%
Net profit · FY 2025
₹15.08 Lakh margin 0.2%
EBITDA · FY 2025
₹50.27 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 258%
5 years · compounded
▲ 234%
EBITDA CAGR growth
1 year
▲ 116%
3 years · compounded
▲ 157%
5 years · compounded
▲ 192%
Revenue has grown at a compounded annual rate (CAGR) of 234% over five years, including 28% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Casid Pharmaceuticals Private Limited, buy the company report.
Board of directors of Casid Pharmaceuticals Private Limited
Casid Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Kathiravan | Director | 02 May 2024 | 2 Years 6 Months | Current |
| Shivakumar Nagulan | Director | 13 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Casid Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aleris Pharmaceuticals Limited | ₹75.07 Cr (FY 2025) | Kolkata, West Bengal, India | ||||
| Biochemical and Synthetic Products Private Limited | ₹74.99 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Farista Vanijya Private Limited | ₹74.9 Cr (FY 2024) | 25.0% | Sonapur Hat, West Bengal, India | |||
| Atlas Pharmachem Industries Private Limited | ₹74.83 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Casid Pharmaceuticals Private Limitedthis company | ₹74.41 Cr (FY 2025) | ₹15.08 Lakh | 0.2% | 28.0% | Manachanalloor, Tamil Nadu, India | |
| Sreepathi Pharmaceuticals Limited | ₹74.26 Cr (FY 2025) | -17.0% | Telangana, India | |||
| Shreeji Imaging and Diagnostic Centre Private Limited | ₹73.82 Cr (FY 2024) | 11.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Casid Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Casid Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Casid Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Casid Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICC2892D1ZT | Tamil Nadu | Active | 19 Aug 2019 |
To see the full GST registrations and return filing status of Casid Pharmaceuticals Private Limited, buy the company report.
Recent activity
Casid Pharmaceuticals Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Shivakumar Nagulan ceased to be Additional Director on 29 Sep 2025.
AGM
Casid Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Shivakumar Nagulan ceased to be Additional Director.
Ceased
Jeyaraman Senthilkumar ceased to be Director.
Appointed
Shivakumar Nagulan was appointed as Director.
Filing
Casid Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Govindaraj Raja ceased to be Director.
Appointed
Nirmal Kathiravan was appointed as Director.
Ceased
Subburaj Manojkumar ceased to be Director.
Ceased
Kathiravan ceased to be Director.
Incorporation
19 Jul 2019
Casid Pharmaceuticals Private Limited was registered on 19 Jul 2019 with Roc Chennai & aged 7 years 3 months as per MCA records.
Frequently asked questions
Casid Pharmaceuticals is an active private limited company based in Manachanalloor, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 July 2019 (7+ years old) and is registered under CIN U24100TN2019PTC130614.
Casid Pharmaceuticals has 2 current directors:
- Nirmal Kathiravan - Director
- Shivakumar Nagulan - Director
The latest financial statements of Casid Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Casid Pharmaceuticals is 33AAICC2892D1ZT, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Casid Pharmaceuticals is U24100TN2019PTC130614. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Casid Pharmaceuticals was incorporated on 19 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Casid Pharmaceuticals by revenue are Aleris Pharmaceuticals Limited, Biochemical and Synthetic Products Private Limited, Farista Vanijya Private Limited, Atlas Pharmachem Industries Private Limited, Sreepathi Pharmaceuticals Limited and 1 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shivakumar Nagulan ceased to be Additional Director on 29 Sep 2025. Jeyaraman Senthilkumar ceased to be Director on 13 Aug 2025. Shivakumar Nagulan was appointed as Director on 13 Aug 2025. Casid Pharmaceuticals has 7 board changes on record in total.
Yes, Casid Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Casid Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-22-0022808).
The registered office of Casid Pharmaceuticals is at S.F. No. 11515 Trichy To Chennai Trunk Road, Samayyapuram Village And Panchayat Manachanalur Taluk, Manachanalloor, Tamil Nadu, India – 621112.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages